These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35705678)

  • 21. Cisplatin therapy for adenoid cystic carcinoma.
    Schramm VL; Srodes C; Myers EN
    Arch Otolaryngol; 1981 Dec; 107(12):739-41. PubMed ID: 6274284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.
    Le Tourneau C; Razak AR; Levy C; Calugaru V; Galatoire O; Dendale R; Desjardins L; Gan HK
    Br J Ophthalmol; 2011 Nov; 95(11):1483-9. PubMed ID: 21183517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of c-kit-positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus imatinib: A case report.
    Demiray M; Sahinbas H; Atahan S; Demiray H; Selcuk D; Yildirim I; Atayoglu AT
    Complement Ther Med; 2016 Aug; 27():108-13. PubMed ID: 27515884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of superselective intra-arterial infusion with concomitant radiotherapy for adenoid cystic carcinoma of the head and neck.
    Homma A; Sakashita T; Hatakeyama H; Kano S; Mizumachi T; Nakamaru Y; Yoshida D; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Acta Otolaryngol; 2015 Sep; 135(9):950-4. PubMed ID: 25925195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of gefitinib in patients with advanced salivary gland cancers.
    Jakob JA; Kies MS; Glisson BS; Kupferman ME; Liu DD; Lee JJ; El-Naggar AK; Gonzalez-Angulo AM; Blumenschein GR
    Head Neck; 2015 May; 37(5):644-9. PubMed ID: 24585506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
    Fukuda N; Fujiwara Y; Wang X; Ohmoto A; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Takahashi S
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3037-3043. PubMed ID: 33219858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma.
    Ross PJ; Teoh EM; A'hern RP; Rhys-Evans PH; Harrington KJ; Nutting CM; Gore ME
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):311-4. PubMed ID: 19201585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenoid cystic carcinoma of the salivary gland. Sustained complete response to chemotherapy.
    Budd GT; Groppe CW
    Cancer; 1983 Feb; 51(4):589-90. PubMed ID: 6295610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
    Laurie SA; Ho AL; Fury MG; Sherman E; Pfister DG
    Lancet Oncol; 2011 Aug; 12(8):815-24. PubMed ID: 21147032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinicopathological features and curative effect of the bronchoscopic interventional therapy combined with radiotherapy for the treatment of locally recurrent lung adenoid cystic carcinoma].
    Zhu DC; Xu JH; Zhang MH; Zhu HX; Zhang Y; Zhang T; Xu GR
    Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):864-868. PubMed ID: 30481940
    [No Abstract]   [Full Text] [Related]  

  • 31. Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
    Choi S; Sano D; Cheung M; Zhao M; Jasser SA; Ryan AJ; Mao L; Chen WT; El-Naggar AK; Myers JN
    Clin Cancer Res; 2008 Aug; 14(16):5081-9. PubMed ID: 18698025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
    Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
    Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
    Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
    J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.
    Chen C; Choudhury S; Wangsa D; Lescott CJ; Wilkins DJ; Sripadhan P; Liu X; Wangsa D; Ried T; Moskaluk C; Wick MJ; Glasgow E; Schlegel R; Agarwal S
    Sci Rep; 2017 Sep; 7(1):11410. PubMed ID: 28900283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.
    Dodd RL; Slevin NJ
    Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
    Hanna GJ; ONeill A; Cutler JM; Flynn M; Vijaykumar T; Clark JR; Wirth LJ; Lorch JH; Park JC; Mito JK; Lohr JG; Kaufman J; Burr NS; Zon LI; Haddad RI
    Oral Oncol; 2021 Aug; 119():105366. PubMed ID: 34091189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR4 antagonist inhibits perineural invasion of adenoid cystic carcinoma.
    Jeong WJ; Choi IJ; Park MW; An SY; Jeon EH; Paik JH; Sung MW; Ahn SH
    J Clin Pathol; 2014 Nov; 67(11):992-8. PubMed ID: 25118295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland.
    Krucoff KB; Shammas RL; Stoecker M; Tolnitch LA
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30068574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular approaches to systemic therapy of adenoid cystic carcinoma of the head and neck area].
    Büchsenschütz K; Veit JA; Schuler PJ; Thierauf J; Laban S; Fahimi F; Bankfalvi A; Lang S; Sauerwein W; Hoffmann TK
    Laryngorhinootologie; 2014 Oct; 93(10):657-64. PubMed ID: 25302595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenoid cystic carcinoma of the lacrimal gland: rare … lethal … cured?
    Bradley EA; Bradley DJ
    Ophthalmology; 2013 Jul; 120(7):1311-2. PubMed ID: 23823505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.